Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.
Press releases published on August 5, 2025

Christie Medical Holdings, Inc is Now a Vizient Contracted Supplier, Expanding Access to VeinViewer® Technology
Christie VeinViewer® vascular imaging is accepted as a Vizient® contracted supplier, nation's largest provider-driven healthcare performance improvement company FL, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- Christie Medical Holdings, Inc ( …

Alcohol Ethoxylates Market Size, Share & Trends Analysis Report By Product
The Business Research Company's Alcohol Ethoxylates Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 6, 2025 /EINPresswire.com/ -- "Get 30% Off All Global Market Reports With …

Hopped Malt Extract Market is Forecasted to Reach a Value of US $15.62 Billion by 2029
The Business Research Company's Hopped Malt Extract Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 6, 2025 /EINPresswire.com/ -- What Is The Expected CAGR For The Hopped Malt …

Avid Solutions Welcomes Cory Hammaker as Director of Business Development, Life Sciences
Avid Solutions, is proud to announce the appointment of Cory Hammaker as its new Director of Business Development, Life Sciences. WINSTON-SALEM, NC, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- Avid Solutions, a leader in industrial automation …

Polyclonal Antibody Market Fueled by Immunodiagnostic Advances | DataM Intelligence
Polyclonal Antibody Market grows with rising use in immunodiagnostics, infectious disease testing, cancer research, and advancements in antibody production. NEW YORK, NY, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- The global polyclonal antibody …

Pet Supplements Market Forecast Reveals Unexpected Growth Opportunities (2025–2034)
Analyze global Pet Supplements Market size, key players, and forecast driven by rising focus on pet wellness and immunity. NEW YORK, NY, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- The Global Research Report Provides a Detailed Analysis of Pet …

Eyewear Frames Market Forecast Reveals Unexpected Growth Opportunities (2025–2034)
Explore trends, size, and growth outlook of the Eyewear Frames Market driven by fashion, tech, and rising vision care needs. NEW YORK, CA, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- The Global Research Report Provides a Detailed Analysis of …

Telemedicine Market Forecast Reveals Unexpected Growth Opportunities (2025–2034)
Analyze global Telemedicine Market growth, key players, and future outlook in digital health and virtual care services. NEW YORK, CA, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- The Global Research Report Provides a Detailed Analysis of …

Pet Food Market Forecast Reveals Unexpected Growth Opportunities (2025–2034)
Analyze global Pet Food Market insights, demand trends, key players, and future outlook in natural and organic pet nutrition NEW YORK, CA, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- The Global Research Report Provides a Detailed Analysis of Pet …

3D printing in healthcare Market Forecast Reveals Unexpected Growth Opportunities (2025–2034)
Analyze the 3D Printing in Healthcare Market trends, size, growth drivers …

Healthcare Mobility Market Forecast Reveals Unexpected Growth Opportunities (2025–2034)
Explore trends …

Exosomes Market Advances Through AI-Driven Biomarker Discovery Trends | DataM Intelligence
DataM Intelligence forecasts robust exosome market growth fueled by AI-driven diagnostics, automated manufacturing, and strategic pharma–CMO partnerships. CONNECTICUT, CT, UNITED STATES, August 5, 2025 /EINPresswire.com/ -- The global exosomes market …

Nxera Launches Broad Proprietary Pipeline Targeting Obesity and Chronic Weight Management
Pipeline led by a new proprietary oral small molecule GLP-1 agonist and six additional innovative programs targeting the GIP, Amylin and Apelin receptors, aiming to transform treatment landscape Designed to address emerging areas of patient need, including …

Respiree Secures Second FDA 510(k) Clearance, Expands Cardio-Respiratory Wearable to Home Use via 1Bio™ Connected Care Platform
HOUSTON and SINGAPORE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, today announced it has received its second U.S. Food …

Praxis Precision Medicines to Participate in Upcoming Fireside Chat
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …

Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations
DURHAM, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the appointment of Tracy Krumme as senior vice president, investor relations, succeeding Hima Inguva in this role …

BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025
MELVILLE, N.Y., Aug. 05, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced …

Galecto Reports Second Quarter 2025 Operating and Financial Results
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced its operating and financial results for the quarter …

Fractyl Health Announces Proposed Public Offering
BURLINGTON, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company” or “Fractyl”), a metabolic therapeutics company pioneering pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (“T2D”), …

Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025
JUPITER, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional …